UFP Technologies, Inc. Proceeds from Lines of Credit
UFP Technologies, Inc. (UFPT) reported Proceeds from Lines of Credit of $53.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-08-06
- UFP Technologies, Inc. proceeds from lines of credit for the quarter ending 2026-06-30 was $19.72M, a 162.93% increase year-over-year.
- UFP Technologies, Inc. proceeds from lines of credit for the quarter ending 2026-03-31 was $33.35M, a 270.56% increase year-over-year.
- UFP Technologies, Inc. proceeds from lines of credit for the quarter ending 2025-12-31 was $68.70M, a 56.14% increase year-over-year.
- UFP Technologies, Inc. proceeds from lines of credit for the quarter ending 2025-09-30 was -$16.50M, a 123.57% decline year-over-year.
- UFP Technologies, Inc. proceeds from lines of credit for fiscal 2025 was $68.70M, a 56.85% decline from fiscal 2024.
- UFP Technologies, Inc. proceeds from lines of credit for fiscal 2024 was $159.20M, a 1668.89% increase from fiscal 2023.
- UFP Technologies, Inc. proceeds from lines of credit for fiscal 2023 was $9.00M, a 79.55% decline from fiscal 2022.
- UFP Technologies, Inc. proceeds from lines of credit for fiscal 2022 was $44.00M, a 26.30% increase from fiscal 2021.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $53.07M 10-Q · filed 2026-08-06 | $121.77M derived: sum of 3 quarters · filed 2026-08-06 | $105.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $33.35M 10-Q · filed 2026-05-08 | $102.05M derived: sum of 2 quarters · filed 2026-05-08 | $85.55M derived: sum of 3 quarters · filed 2026-05-08 | $93.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $68.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $52.20M derived: sum of 2 quarters · filed 2026-02-27 | $59.70M derived: sum of 3 quarters · filed 2026-08-06 | $68.70M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$16.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$9.00M derived: sum of 2 quarters · filed 2026-08-06 | $0.00 10-Q · filed 2025-11-07 | $44.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $16.50M 10-Q · filed 2026-08-06 | $60.50M derived: sum of 3 quarters · filed 2026-08-06 | $130.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $9.00M 10-Q · filed 2026-05-08 | $53.00M derived: sum of 2 quarters · filed 2026-05-08 | $123.00M derived: sum of 3 quarters · filed 2026-05-08 | $161.20M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $44.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $114.00M derived: sum of 2 quarters · filed 2026-02-27 | $152.20M derived: sum of 3 quarters · filed 2026-02-27 | $159.20M 10-K · filed 2026-02-27 |
| 2024-09-30 | $70.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $108.20M derived: sum of 2 quarters · filed 2025-11-07 | $115.20M 10-Q · filed 2025-11-07 | $115.20M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $38.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $45.20M 10-Q · filed 2025-08-11 | $45.20M derived: sum of 3 quarters · filed 2026-02-27 | $45.20M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $7.00M 10-Q · filed 2025-05-12 | $7.00M derived: sum of 2 quarters · filed 2026-02-27 | $7.00M derived: sum of 3 quarters · filed 2026-02-27 | $10.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $3.00M derived: sum of 3 quarters · filed 2026-02-27 | $9.00M 10-K · filed 2026-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.00M derived: sum of 2 quarters · filed 2024-11-12 | $9.00M 10-Q · filed 2024-11-12 | $9.00M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $9.00M 10-Q · filed 2024-08-09 | $9.00M derived: sum of 3 quarters · filed 2025-03-03 | $19.00M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $6.00M 10-Q · filed 2024-05-10 | $6.00M derived: sum of 2 quarters · filed 2025-03-03 | $16.00M derived: sum of 3 quarters · filed 2025-03-03 | $22.00M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $10.00M derived: sum of 2 quarters · filed 2025-03-03 | $16.00M derived: sum of 3 quarters · filed 2025-03-03 | $44.00M 10-K · filed 2025-03-03 |
| 2022-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $16.00M derived: sum of 2 quarters · filed 2023-11-09 | $44.00M 10-Q · filed 2023-11-09 | $78.84M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $34.00M 10-Q · filed 2023-08-09 | $68.84M derived: sum of 3 quarters · filed 2024-02-29 | $68.84M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $28.00M 10-Q · filed 2023-05-10 | $62.84M derived: sum of 2 quarters · filed 2024-02-29 | $62.84M derived: sum of 3 quarters · filed 2024-02-29 | $62.84M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $34.84M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-02-29 | $34.84M derived: sum of 2 quarters · filed 2024-02-29 | $34.84M derived: sum of 3 quarters · filed 2024-02-29 | $34.84M 10-K · filed 2024-02-29 |
| 2021-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q/A · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-03-16 | $0.00 derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $0.00 derived: sum of 3 quarters · filed 2023-03-16 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $5.50M 10-K · filed 2023-03-16 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $5.50M 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | $5.50M 10-Q · filed 2021-08-06 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $0.00 derived: sum of 2 quarters · filed 2022-03-14 | $0.00 10-K · filed 2022-03-14 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-07 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $36.00M 10-K · filed 2021-03-12 | ||
| 2018-09-30 | $36.00M 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |